Product Description
Overall, the global motion preservation device market was valued at $1.1 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $1.4 billion.
Throughout this medical market research, we analyzed over 12 motion preservation device companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for motion preservation devices extends its projections up to the year 2028, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2028, and Historical Data to 2018
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Motion Preservation Device Market Insights 
A significant factor propelling the market is the patient’s inclination towards motion preservation as opposed to spinal fusion. Artificial discs are designed to either restore or sustain the natural motion of the human spine, contrasting with fusion procedures that considerably restrict motion. Research indicates that, disregarding cost considerations, patients generally express a preference for motion-preserving devices when given the option between fusion and such devices.
Global Motion Preservation Device Market Share Insights 
- In 2021, Zimmer Biomet emerged as the leading company in the global motion preservation market, holding the top position in most regions. The success of Zimmer Biomet in this market can be attributed to the popularity of its Mobi-C® cervical artificial disc and Dynesys® posterior stabilization systems.
- Medtronic secured the second position in the global motion preservation market in 2021. While the company held the first place in a few countries, it generally maintained the second position in most other regions. Medtronic‘s Prestige®, the first artificial disc approved by the FDA for use in the cervical spine, played a significant role in the company’s standing.
- Centinel Spine held the third position in the global motion preservation market in 2021. The company achieved high market shares in almost all regions, primarily driven by the success of its ProDisc®-L and ProDisc®-C product lines. These product lines contributed significantly to Centinel Spine‘s standing in the competitive landscape of the motion preservation market.
Market Segmentation Summary
- Artificial Disc Device Market
- Dynamic Stabilization Device Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
